Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check2 days agoChange DetectedNaples, Italy (80131) was added as a study site and Napoli, Italy (80131) was removed; Abbotsford listing formatting was updated to Abbotsford British Columbia, British Columbia, Canada, V2S 0C2.SummaryDifference0.1%

- Check10 days agoChange Detected- Revision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a publication entry for LEAP-005 colorectal cancer results with the full author list; updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedGastric cancer was added to the list of conditions, and the page revision was updated to v3.4.2.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.1 replaces the prior v3.4.0; no user-facing content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedGlossary visibility has been added and new timestamp fields such as Results First Posted and Last Update Posted were introduced, while older timestamp labels and No FEAR Act data were removed and the revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.